CDP and the MMI start up: focus on venture capital

CDP and the MMI start up: focus on venture capital

The Pisa-based company is working on the marketing of a micro-clamp for precision surgery, with the support of the Cassa Depositi e Prestiti Group.

The potential market is very attractive: US$2.5 billion. The start up from Pisa that is preparing the landing on the market for 2020 is called MMI and has very clear ideas: to produce microsurgical clamps capable of working with materials one millimetre thick or even less. The CDP Group, through the Fondo Italiano d’Investimento (Italian Investment Fund), is investing in a project that has already brought concrete results in terms of technological excellence and quality of service for the community.

MMI has in fact developed the first teleoperated robotic platform for suturing in open-air surgery, with articulated micro-instruments. The platform allows the surgeon’s movement to be scaled, increasing its precision, and aims to both facilitate existing procedures and enable new ones in the field of microsurgery, from post-oncological and traumatic reconstructions to ophthalmology, organ transplantation and paediatric surgery.

The Fondo Italiano d’Investimento, 43% owned by Cassa Depositi e Prestiti, used its Venture Capital instrument FII sgr to support MMI, through the Panakes fund. Giuseppe Prisco, CEO of MMI, commented: “We are excited to have this exceptional group of investors and MedTech experts for the next phase of the company’s development.” The financing is in fact aimed at completing the development of the product, with its CE certification and its launch in European markets.

An effort in line with the strategies of the CDP Group and its Business Plan: technological innovation that is “made in Italy”, competitiveness of Italian companies on the international market, professional opportunities with positive repercussions on the territory, on community services and on the future of the country.